c ebpβ-lip drug Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | Journal of Experimental & Clinical Cancer Research Alignment of CEBPb isoforms LAP*,
Alignment of CEBPb isoforms LAP*, LAP, and LIP created and annotated Download Scientific Diagram A screening strategy for the discovery of drugs that reduce C EBP LIP translation with potential calorie restriction mimetic properties Scientific Reports Transcriptional Control of COX 2 via C EBP Arteriosclerosis, Thrombosis, and Vascular Biology Purified anti C EBP beta 2 isoforms C EBP beta, LAP
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




